Clarence S. Rooney

Statistics

Publications

Citations

516

H-Index

Active since

1968

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Clarence S. Rooney is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, chemistry, and molecular pharmacology.

Publications per year

1968–1993

Publications

5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase

Theresa M. Williams, Terrence M. Ciccarone, Suzanne C. MacTough et al. · Journal of Medicinal Chemistry · 1993 · 267 citations · Full text

Medicine, Chemistry, Pharmacology +13

Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 4. 3-[2-(Benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one and analogs

J. M. HOFFMAN, Anthony M. Smith, Clarence S. Rooney et al. · Journal of Medicinal Chemistry · 1993 · 79 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Synthesis and evaluation of 2-pyridinone derivatives as specific HIV-1 reverse transcriptase inhibitors. 3. Pyridyl and phenyl analogs of 3-aminopyridin-2(1H)-one

John Wai, Theresa M. Williams, Dona L. Bamberger et al. · Journal of Medicinal Chemistry · 1993 · 45 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Cyclic amidine inhibitors of indolamine N-methyltransferase

Joshua Rokach, Pierre Hamel, Norman R. Hunter et al. · Journal of Medicinal Chemistry · 1979 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

1,8‐Naphthyridines. Part I. Synthesis of some trifluoromethyl‐1,8‐naphthyridine derivatives

Eva Eichler, Clarence S. Rooney, H. W. R. WILLIAMS · Journal of Heterocyclic Chemistry · 1976 · 29 citations

Natural Sciences, Chemistry, Medicinal Chemistry +9

1–5 of 8